Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/2010
10/06/2010EP1513543B1 Fas peptide mimetics and uses thereof
10/06/2010EP1456650B1 Gfats as modifiers of the p53 pathway and methods of use
10/06/2010EP1421105B1 Anti-cancer cyclopenta¬g quinazoline compounds
10/06/2010EP1220906B1 Polynucleotides encoding members of the human b lymphocyte activation antigen b7 family and polypeptides encoded thereby
10/06/2010EP1131457B1 Systemic viral/ligand gene delivery system and gene therapy
10/06/2010EP1100880B1 Urate oxidase
10/06/2010EP0873363B1 High affinity human antibodies to tumor antigens
10/06/2010CN1878570B Stable pharmaceutical composition comprising granulocyte-colony stimulating factor
10/06/2010CN1711108B Method for the selective and quantitative functionalization of immunoglobulin Fab fragments, conjugate compounds obtained with the same and compositions thereof
10/06/2010CN101855344A Modified lecithin-cholesterol acyltransferase enzymes
10/06/2010CN101855240A Improved derivatives of amylin
10/06/2010CN101855237A Peptide ligand directed drug delivery
10/06/2010CN101855236A Detection and quantitation of urine gelsolin
10/06/2010CN101854948A Mixture comprising an amylin peptide and a protracted insulin
10/06/2010CN101854947A Agents and methods for modulating macrophage inhibitory cytokine (MIC-1) activity
10/06/2010CN101854946A Recombinant monoclonal antibodies and corresponding antigens for colon and pancreatic cancers
10/06/2010CN101854945A Ctl inducer composition
10/06/2010CN101854937A Novel stat3 pathway inhibitors and cancer stem cell inhibitors
10/06/2010CN101854936A Dose forms comprising VX- 950 and their dosage regimen
10/06/2010CN101854917A Vesicles comprising a transmembrane transport trigger system
10/06/2010CN101854916A Sustained delivery of compstatin analogs from gels
10/06/2010CN101854914A Stable formulations of amylin and its analogues
10/06/2010CN101852781A HPLC analysis and detection method of cyclosporine A
10/06/2010CN101851636A Recombinant influenza viruses for vaccines and gene therapy
10/06/2010CN101851635A Preparation method for novel fusion protein reversing renal fibrosis and activity detection
10/06/2010CN101851627A Gene encoding protein of eriocheir sinensis cysteine protease inhibitor Escystatin and application
10/06/2010CN101851294A Cell-penetrating peptide (Arg) 9 and lidamycin fusion protein (Arg) 9-LDP
10/06/2010CN101851293A Long-acting glucagon-like peptide-2 and application thereof
10/06/2010CN101851288A Analogs of parathyroid hormone
10/06/2010CN101851287A Menopausal gonadotropin with high specific activity as well as preparation method and application thereof
10/06/2010CN101851286A Mammalian cytokine: interleukin-B30 and related reagents
10/06/2010CN101851280A Plectasin mature polypeptide dimer fusion protein and preparation method thereof
10/06/2010CN101851279A Pseudomonas aeruginosa antigens
10/06/2010CN101851278A B cell activating factor antagonist as well as preparation method and application thereof
10/06/2010CN101851275A Dimerized peptide
10/06/2010CN101851274A Polypeptides for suppressing invasion of hepatitis C virus
10/06/2010CN101851273A Glaucocalyxin A derivative, preparation method and application thereof
10/06/2010CN101851272A Glaucocalyxin B, derivative, preparation method and application thereof
10/06/2010CN101851271A Glaucocalyxin D derivative, preparation method and application thereof
10/06/2010CN101850120A Solutions and methods for inhibition of pain, inflammation and cartilage degradation
10/06/2010CN101850110A Novel medicinal composition and preparation method
10/06/2010CN101850109A Smoke-resisting cancer prevention compound
10/06/2010CN101850108A Methods and pharmaceutical compositions for healing wounds
10/06/2010CN101850107A Application of skeleton protein source polypeptide in preparing medicines for restraining invasion and transfer of colorectal cancer cells
10/06/2010CN101850106A Application of pumpkin protein in preparing medicine for treating pancreatic cancer
10/06/2010CN101850105A Cefuroxime sodium composite medicine
10/06/2010CN101850104A Clindamycin hydrochloride composition medicine
10/06/2010CN101850103A Clindamycin phosphate composite medicine
10/06/2010CN101850102A Sodium glucuronate composite medicine
10/06/2010CN101849948A Cefuroxime axetil composite medicine
10/06/2010CN101849924A Mucoadhesive erodible drug delivery device for controlled administration of pharmaceuticals and other active compounds
10/06/2010CN101849675A Dietary supplements containing natural ingredients
10/06/2010CN101334356B Gas sensors
10/06/2010CN101279089B Donkey-hide gelatin calcium composition and preparing process thereof
10/06/2010CN101113163B Hla-a24-restricted cancer antigen peptides
10/06/2010CN101039660B Stable pegylated interferon formulation
10/06/2010CN100999550B Tubercle branch bacillus fusion protein and application thereof
10/05/2010US7807822 Purification of plasmid nucleotide sequences from bacterial cells; obtain cells, lyse, precipatate, centrifuge precipitate mixture, expose to ion exchange column, recover nucleotide sequences
10/05/2010US7807818 Reverse-sense nucleotide sequences for use in treatment of ulcerative colitis, crohn's and/or inflammatory bowel disease
10/05/2010US7807805 isolated nucleic acid encoding an immunogenic peptide recognized by T lymphocytes; host cell transfected with the recombinant expression vector encoding an immunogenic protein; diagnosis of skin cancer; vaccine for prevention and treatment; immunotherapy
10/05/2010US7807803 For prophylaxis and therapy of infectious disease, allergy, cancer
10/05/2010US7807798 Epidermal growth factor receptor specific immunoglobulin for use in treatment of cell proliferative disorders; antitumor agents
10/05/2010US7807796 ULBP antibodies
10/05/2010US7807795 Antibodies to osteoprotegerin binding proteins
10/05/2010US7807793 Antiallergenics; reducing eosinophil inflammation as antiproliferation agents of IL5 secreting cells and inhibiters of adherence mechanism
10/05/2010US7807792 Wilms tumor protein-1 (WT1) for use in treatment and prevention of celll proliferative disorders; antitumor agents
10/05/2010US7807787 NELL-1 (Nel-like molecule-1) polypeptide for use in induction and treatment of bone formation and disorders
10/05/2010US7807786 Activation antigen expressed on B-cells for treating conditions associated with aberrant or increased T-cell proliferation
10/05/2010US7807783 Fas associating protein with a novel death domain(FADD) for use in treatment and prevention programmed cell death associated disorders
10/05/2010US7807781 Bactericides; viricides; administering antitrypsin peptide
10/05/2010US7807780 Multi-component biological transport systems
10/05/2010US7807779 Salt with physiologically tolerated acid; resistant to enzymatic degradation; oral administration, tumor therapy
10/05/2010US7807778 Cysteine-containing peptide tag for site-specific conjugation of proteins
10/05/2010US7807777 Marker peptide for alzheimer's disease
10/05/2010US7807678 Peptidomimetics of biologically active metallopeptides
10/05/2010US7807663 Therapeutic agents for diabetes
10/05/2010US7807649 Antisense oligonucleotides; diabetes, rhabdomyosarcoma; screening for the modulators
10/05/2010US7807645 Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment
10/05/2010US7807644 Chimeric proteins with phosphatidylserine binding domains
10/05/2010US7807643 Compositions containing leptin
10/05/2010US7807642 Tumor-associated peptides binding promiscuosly to human leukocyte antigen (HLA) class II molecules
10/05/2010US7807641 Methods and reagents for treating glucose metabolic disorders
10/05/2010US7807640 stimulate the formation and cycling of pre-beta high density lipoprotein-like particles and/or promote lipid transport and detoxification and inhibit osteoporosis; class A amphipathic helix when formulated with "D" amino acid residue(s) and/or having protected amino and carboxyl termini; atherosclerosis
10/05/2010US7807639 Methods for preventing and treating local tracheal, bronchial or alveolar bleeding or hemoptysis
10/05/2010US7807638 Amino acid substitution in position 36; brain bleeding, hemorrhage, trauma or injury; genetic engineering and expression; biodrugs, anticoagulants
10/05/2010US7807637 antibiotics treating bacteria infection caused by a Gramnegative bacterium; peptide with attached fatty acid tail; reducing the nephrotoxicity, and improving the pharmacokinetic properties; sepsis
10/05/2010US7807636 Antiinflammatory ligand for use in prevention and treatment of intestinal ischemia, salmonellosis and/or sepsis; biodrug for reducing or preventing damage to tissue or organs caused by acute inflammatory response in a bovine; veterinary medicine
10/05/2010US7807635 Pan-antiviral peptides for protein kinase inhibition
10/05/2010US7807634 multilayer film comprising layers of polyelectrolytes; antigenic polypeptide comprising surface adsorption regions covalently linked to antigenic determinant regions; parasite antigen; eliciting an immune response in a vertebrate organism; vaccines drug delivery device
10/05/2010US7807633 Immunogenic compositions and methods of use
10/05/2010US7807632 Multilayer thin film comprising two or more adjacent layers of oppositely charged polyelectrolytes and encapsulated antigenic peptides; eliciting an immune response in a vertebrate organism; vaccine development for hepatitis B virus, HIV, bacteria, parasites, and viruses
10/05/2010US7807631 administering a fusion protein biodrug treating muscle wasting condition of Autoimmune Deficiency Syndrome (AIDS), Multiple Sclerosis, and cancer; Lou Gehrig's Disease; antagonists; stroke, spinal cord injury, and all peripheral nerve diseases; useful as GH (growth hormone) equivalent
10/05/2010US7807630 Targeting of Notch3 receptor function for cancer therapy
10/05/2010US7807629 topical administering a bradykinin B2 receptor agonist; without side-effects; controlling intraocular pressure
10/05/2010US7807628 Therapeutic agent for dentin-pulp complex regeneration
10/05/2010US7807627 treating bone disorders related to bone, cartilage, tendon or tooth formation; recombinant BMP protein having a heparin binding site; expressing a BMP protein in a bacterial E. Coli host; low immunogenicity
10/05/2010US7807626 inhibiting prostate cancer cell proliferation and causing prostate cancer cell apoptosis; administering a biodrug with amino acid sequence; anticarcinogenic agents
10/05/2010US7807625 acylated palmitoyl hexapeptide and a plant extract of Lycium barbarum; for cosmetic treating the skin, improving the dermal fibroblast, increase collagen production; synergistic
10/05/2010US7807623 Use of pentagastrin to inhibit gastric acid secretion or as a diuretic
10/05/2010US7807621 end capped sequence OCTAPEPTIDE; ANTITUMOR AGENT; antiproliferative agent; angiogenesis inhibitors
1 ... 574 575 576 577 578 579 580 581 582 583 584 585 586 587 588 589 590 591 592 593 594 ... 3163